Invirsa
0 followers
‌
Invirsa is developing a small molecule (INV-102) that promotes both DNA repair and the innate immune response to infection and injury. These actions lead to enhanced wound healing associated with reductions in inflammation and viral replication.
Industries
Headquarters
Employees
Links
Org chart
Robert Shalwitz
Founder & CEO
Robert Shalwitz
Collapse
Rachael Wingo
Chief Financial Officer
Isaiah Shalwitz
VP, Business Development & Operations
Cindy Flinn
Senior Director Program Management
Alexandrea M.
Manager of CMC and R&D
Faith V.
Board Director
